Patents by Inventor Jan Johan Adriaan Tuiten

Jan Johan Adriaan Tuiten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 8669242
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: July 10, 2012
    Date of Patent: March 11, 2014
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction
    Patent number: 8653051
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: February 18, 2014
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction
    Patent number: 8648060
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: February 11, 2014
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140038929
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 6, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1a agonist in the treatment of sexual dysfunction
    Patent number: 8575139
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: November 5, 2013
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20120277200
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: July 10, 2012
    Publication date: November 1, 2012
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20120264722
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: June 21, 2012
    Publication date: October 18, 2012
    Applicant: Emotional Brain B.V.
    Inventor: Jan Johan Adriaan TUITEN
  • Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
    Patent number: 8227453
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Grant
    Filed: November 10, 2006
    Date of Patent: July 24, 2012
    Assignee: Emotional Brain B.V.
    Inventor: Jan Johan Adriaan Tuiten
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20100160270
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: November 2, 2007
    Publication date: June 24, 2010
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20100152145
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: November 2, 2007
    Publication date: June 17, 2010
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20100093680
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: November 2, 2007
    Publication date: April 15, 2010
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange